| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |